 random placebo-control trial erythromycin treatment ureaplasma urealyticum prematur deliveri vagin infect prematur studi group ureaplasma urealyticum low birth weight histolog chorioamnion frequent isol chorioamnion patient prior clinic trial antibiot activ urealyticum antibiot treatment reduc prematur mean birth weight multicent double-blind clinic trial pregnant women urealyticum mg erythromycin base placebo time week gestat complet week pregnanc women urinari tract infect neisseria gonorrhoea infect trial women chlamydia trachomati group streptococci analys erythromycin urealyticum genit tract signific differ erythromycin- placebo-tr women infant birth gestat age deliveri frequenc prematur ruptur membran neonat outcom